HEPATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=529975, encodeId=a44e5299e553, content=投了另一个杂志，已经接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Tue Nov 29 14:18:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529402, encodeId=cb55529402c2, content=意思是，现在他们觉得有一个其他杂质可能适合你的文章，他们问你是否需要把你的这篇文章转给这个杂志进行审稿。假如该文章接收，这个新杂志将会收取版面费。如果你同意他们就帮你转过去，你就不用再重新走投稿的流程了。Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Nov 15 18:18:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529118, encodeId=50bc529118f0, content=今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Tue Nov 08 12:42:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529056, encodeId=51fd52905603, content=我只写了cover letter，decision letter是什么，第一次发sci，不是很懂，只是按照稿约里写的。我投的是篇case report。我今天用传真传过去了，也不知道那边能不能知道是我的author agreementifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, beContent=ifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Sun Nov 06 14:00:00 CST 2016, time=2016-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529034, encodeId=0a1052903454, content=发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sat Nov 05 21:15:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528925, encodeId=d51052892521, content=投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Thu Nov 03 10:03:00 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528482, encodeId=885652848229, content=您的文章接受了没，希望可以拜读一下miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e191689492, createdName=1de54751m01(暂无匿称), createdTime=Fri Oct 21 12:11:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528368, encodeId=8add5283681c, content=投了个correspondence，昨天已经接收啦。ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=599, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Oct 18 18:01:00 CST 2016, time=2016-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527772, encodeId=b52052e77246, content=投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Fri Sep 30 08:53:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527252, encodeId=2d9552e252f7, content=请问您文章后续怎样啊我的选审稿人都两周了miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Sat Sep 17 09:24:00 CST 2016, time=2016-09-17, status=1, ipAttribution=)]

2016-11-29 后宫三千

投了另一个杂志，已经接受了

376 0

[GetPortalCommentsPageByObjectIdResponse(id=529975, encodeId=a44e5299e553, content=投了另一个杂志，已经接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Tue Nov 29 14:18:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529402, encodeId=cb55529402c2, content=意思是，现在他们觉得有一个其他杂质可能适合你的文章，他们问你是否需要把你的这篇文章转给这个杂志进行审稿。假如该文章接收，这个新杂志将会收取版面费。如果你同意他们就帮你转过去，你就不用再重新走投稿的流程了。Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Nov 15 18:18:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529118, encodeId=50bc529118f0, content=今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Tue Nov 08 12:42:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529056, encodeId=51fd52905603, content=我只写了cover letter，decision letter是什么，第一次发sci，不是很懂，只是按照稿约里写的。我投的是篇case report。我今天用传真传过去了，也不知道那边能不能知道是我的author agreementifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, beContent=ifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Sun Nov 06 14:00:00 CST 2016, time=2016-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529034, encodeId=0a1052903454, content=发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sat Nov 05 21:15:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528925, encodeId=d51052892521, content=投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Thu Nov 03 10:03:00 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528482, encodeId=885652848229, content=您的文章接受了没，希望可以拜读一下miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e191689492, createdName=1de54751m01(暂无匿称), createdTime=Fri Oct 21 12:11:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528368, encodeId=8add5283681c, content=投了个correspondence，昨天已经接收啦。ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=599, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Oct 18 18:01:00 CST 2016, time=2016-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527772, encodeId=b52052e77246, content=投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Fri Sep 30 08:53:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527252, encodeId=2d9552e252f7, content=请问您文章后续怎样啊我的选审稿人都两周了miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Sat Sep 17 09:24:00 CST 2016, time=2016-09-17, status=1, ipAttribution=)]

2016-11-15 ifmorethanten

意思是，现在他们觉得有一个其他杂质可能适合你的文章，他们问你是否需要把你的这篇文章转给这个杂志进行审稿。假如该文章接收，这个新杂志将会收取版面费。如果你同意他们就帮你转过去，你就不用再重新走投稿的流程了。Milk An 2016-11-08 发表::
今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导

Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导

325 0

[GetPortalCommentsPageByObjectIdResponse(id=529975, encodeId=a44e5299e553, content=投了另一个杂志，已经接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Tue Nov 29 14:18:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529402, encodeId=cb55529402c2, content=意思是，现在他们觉得有一个其他杂质可能适合你的文章，他们问你是否需要把你的这篇文章转给这个杂志进行审稿。假如该文章接收，这个新杂志将会收取版面费。如果你同意他们就帮你转过去，你就不用再重新走投稿的流程了。Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Nov 15 18:18:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529118, encodeId=50bc529118f0, content=今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Tue Nov 08 12:42:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529056, encodeId=51fd52905603, content=我只写了cover letter，decision letter是什么，第一次发sci，不是很懂，只是按照稿约里写的。我投的是篇case report。我今天用传真传过去了，也不知道那边能不能知道是我的author agreementifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, beContent=ifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Sun Nov 06 14:00:00 CST 2016, time=2016-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529034, encodeId=0a1052903454, content=发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sat Nov 05 21:15:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528925, encodeId=d51052892521, content=投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Thu Nov 03 10:03:00 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528482, encodeId=885652848229, content=您的文章接受了没，希望可以拜读一下miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e191689492, createdName=1de54751m01(暂无匿称), createdTime=Fri Oct 21 12:11:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528368, encodeId=8add5283681c, content=投了个correspondence，昨天已经接收啦。ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=599, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Oct 18 18:01:00 CST 2016, time=2016-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527772, encodeId=b52052e77246, content=投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Fri Sep 30 08:53:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527252, encodeId=2d9552e252f7, content=请问您文章后续怎样啊我的选审稿人都两周了miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Sat Sep 17 09:24:00 CST 2016, time=2016-09-17, status=1, ipAttribution=)]

2016-11-08 Milk An

今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导

392 0

[GetPortalCommentsPageByObjectIdResponse(id=529975, encodeId=a44e5299e553, content=投了另一个杂志，已经接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Tue Nov 29 14:18:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529402, encodeId=cb55529402c2, content=意思是，现在他们觉得有一个其他杂质可能适合你的文章，他们问你是否需要把你的这篇文章转给这个杂志进行审稿。假如该文章接收，这个新杂志将会收取版面费。如果你同意他们就帮你转过去，你就不用再重新走投稿的流程了。Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Nov 15 18:18:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529118, encodeId=50bc529118f0, content=今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Tue Nov 08 12:42:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529056, encodeId=51fd52905603, content=我只写了cover letter，decision letter是什么，第一次发sci，不是很懂，只是按照稿约里写的。我投的是篇case report。我今天用传真传过去了，也不知道那边能不能知道是我的author agreementifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, beContent=ifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Sun Nov 06 14:00:00 CST 2016, time=2016-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529034, encodeId=0a1052903454, content=发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sat Nov 05 21:15:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528925, encodeId=d51052892521, content=投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Thu Nov 03 10:03:00 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528482, encodeId=885652848229, content=您的文章接受了没，希望可以拜读一下miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e191689492, createdName=1de54751m01(暂无匿称), createdTime=Fri Oct 21 12:11:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528368, encodeId=8add5283681c, content=投了个correspondence，昨天已经接收啦。ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=599, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Oct 18 18:01:00 CST 2016, time=2016-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527772, encodeId=b52052e77246, content=投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Fri Sep 30 08:53:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527252, encodeId=2d9552e252f7, content=请问您文章后续怎样啊我的选审稿人都两周了miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Sat Sep 17 09:24:00 CST 2016, time=2016-09-17, status=1, ipAttribution=)]

2016-11-06 Milk An

我只写了cover letter，decision letter是什么，第一次发sci，不是很懂，只是按照稿约里写的。我投的是篇case report。我今天用传真传过去了，也不知道那边能不能知道是我的author agreementifmorethanten 2016-11-05 发表::
发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。

ifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。

287 0

[GetPortalCommentsPageByObjectIdResponse(id=529975, encodeId=a44e5299e553, content=投了另一个杂志，已经接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Tue Nov 29 14:18:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529402, encodeId=cb55529402c2, content=意思是，现在他们觉得有一个其他杂质可能适合你的文章，他们问你是否需要把你的这篇文章转给这个杂志进行审稿。假如该文章接收，这个新杂志将会收取版面费。如果你同意他们就帮你转过去，你就不用再重新走投稿的流程了。Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Nov 15 18:18:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529118, encodeId=50bc529118f0, content=今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Tue Nov 08 12:42:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529056, encodeId=51fd52905603, content=我只写了cover letter，decision letter是什么，第一次发sci，不是很懂，只是按照稿约里写的。我投的是篇case report。我今天用传真传过去了，也不知道那边能不能知道是我的author agreementifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, beContent=ifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Sun Nov 06 14:00:00 CST 2016, time=2016-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529034, encodeId=0a1052903454, content=发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sat Nov 05 21:15:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528925, encodeId=d51052892521, content=投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Thu Nov 03 10:03:00 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528482, encodeId=885652848229, content=您的文章接受了没，希望可以拜读一下miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e191689492, createdName=1de54751m01(暂无匿称), createdTime=Fri Oct 21 12:11:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528368, encodeId=8add5283681c, content=投了个correspondence，昨天已经接收啦。ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=599, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Oct 18 18:01:00 CST 2016, time=2016-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527772, encodeId=b52052e77246, content=投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Fri Sep 30 08:53:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527252, encodeId=2d9552e252f7, content=请问您文章后续怎样啊我的选审稿人都两周了miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Sat Sep 17 09:24:00 CST 2016, time=2016-09-17, status=1, ipAttribution=)]

2016-11-05 ifmorethanten

发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。Milk An 2016-11-03 发表::
投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神

Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神

260 0

[GetPortalCommentsPageByObjectIdResponse(id=529975, encodeId=a44e5299e553, content=投了另一个杂志，已经接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Tue Nov 29 14:18:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529402, encodeId=cb55529402c2, content=意思是，现在他们觉得有一个其他杂质可能适合你的文章，他们问你是否需要把你的这篇文章转给这个杂志进行审稿。假如该文章接收，这个新杂志将会收取版面费。如果你同意他们就帮你转过去，你就不用再重新走投稿的流程了。Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Nov 15 18:18:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529118, encodeId=50bc529118f0, content=今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Tue Nov 08 12:42:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529056, encodeId=51fd52905603, content=我只写了cover letter，decision letter是什么，第一次发sci，不是很懂，只是按照稿约里写的。我投的是篇case report。我今天用传真传过去了，也不知道那边能不能知道是我的author agreementifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, beContent=ifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Sun Nov 06 14:00:00 CST 2016, time=2016-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529034, encodeId=0a1052903454, content=发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sat Nov 05 21:15:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528925, encodeId=d51052892521, content=投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Thu Nov 03 10:03:00 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528482, encodeId=885652848229, content=您的文章接受了没，希望可以拜读一下miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e191689492, createdName=1de54751m01(暂无匿称), createdTime=Fri Oct 21 12:11:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528368, encodeId=8add5283681c, content=投了个correspondence，昨天已经接收啦。ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=599, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Oct 18 18:01:00 CST 2016, time=2016-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527772, encodeId=b52052e77246, content=投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Fri Sep 30 08:53:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527252, encodeId=2d9552e252f7, content=请问您文章后续怎样啊我的选审稿人都两周了miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Sat Sep 17 09:24:00 CST 2016, time=2016-09-17, status=1, ipAttribution=)]

2016-11-03 Milk An

投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神

277 0

[GetPortalCommentsPageByObjectIdResponse(id=529975, encodeId=a44e5299e553, content=投了另一个杂志，已经接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Tue Nov 29 14:18:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529402, encodeId=cb55529402c2, content=意思是，现在他们觉得有一个其他杂质可能适合你的文章，他们问你是否需要把你的这篇文章转给这个杂志进行审稿。假如该文章接收，这个新杂志将会收取版面费。如果你同意他们就帮你转过去，你就不用再重新走投稿的流程了。Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Nov 15 18:18:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529118, encodeId=50bc529118f0, content=今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Tue Nov 08 12:42:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529056, encodeId=51fd52905603, content=我只写了cover letter，decision letter是什么，第一次发sci，不是很懂，只是按照稿约里写的。我投的是篇case report。我今天用传真传过去了，也不知道那边能不能知道是我的author agreementifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, beContent=ifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Sun Nov 06 14:00:00 CST 2016, time=2016-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529034, encodeId=0a1052903454, content=发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sat Nov 05 21:15:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528925, encodeId=d51052892521, content=投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Thu Nov 03 10:03:00 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528482, encodeId=885652848229, content=您的文章接受了没，希望可以拜读一下miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e191689492, createdName=1de54751m01(暂无匿称), createdTime=Fri Oct 21 12:11:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528368, encodeId=8add5283681c, content=投了个correspondence，昨天已经接收啦。ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=599, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Oct 18 18:01:00 CST 2016, time=2016-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527772, encodeId=b52052e77246, content=投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Fri Sep 30 08:53:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527252, encodeId=2d9552e252f7, content=请问您文章后续怎样啊我的选审稿人都两周了miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Sat Sep 17 09:24:00 CST 2016, time=2016-09-17, status=1, ipAttribution=)]

2016-10-21 1de54751m01(暂无匿称)

您的文章接受了没，希望可以拜读一下miamihurricane 2016-05-05 发表::
两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers...

miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers...

282 0

[GetPortalCommentsPageByObjectIdResponse(id=529975, encodeId=a44e5299e553, content=投了另一个杂志，已经接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Tue Nov 29 14:18:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529402, encodeId=cb55529402c2, content=意思是，现在他们觉得有一个其他杂质可能适合你的文章，他们问你是否需要把你的这篇文章转给这个杂志进行审稿。假如该文章接收，这个新杂志将会收取版面费。如果你同意他们就帮你转过去，你就不用再重新走投稿的流程了。Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Nov 15 18:18:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529118, encodeId=50bc529118f0, content=今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Tue Nov 08 12:42:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529056, encodeId=51fd52905603, content=我只写了cover letter，decision letter是什么，第一次发sci，不是很懂，只是按照稿约里写的。我投的是篇case report。我今天用传真传过去了，也不知道那边能不能知道是我的author agreementifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, beContent=ifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Sun Nov 06 14:00:00 CST 2016, time=2016-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529034, encodeId=0a1052903454, content=发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sat Nov 05 21:15:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528925, encodeId=d51052892521, content=投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Thu Nov 03 10:03:00 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528482, encodeId=885652848229, content=您的文章接受了没，希望可以拜读一下miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e191689492, createdName=1de54751m01(暂无匿称), createdTime=Fri Oct 21 12:11:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528368, encodeId=8add5283681c, content=投了个correspondence，昨天已经接收啦。ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=599, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Oct 18 18:01:00 CST 2016, time=2016-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527772, encodeId=b52052e77246, content=投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Fri Sep 30 08:53:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527252, encodeId=2d9552e252f7, content=请问您文章后续怎样啊我的选审稿人都两周了miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Sat Sep 17 09:24:00 CST 2016, time=2016-09-17, status=1, ipAttribution=)]

2016-10-18 ifmorethanten

投了个correspondence，昨天已经接收啦。ifmorethanten 2016-09-30 发表::
投稿两天了，一直是submission recieved。请问有知道是为啥吗？

ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？

599 0

[GetPortalCommentsPageByObjectIdResponse(id=529975, encodeId=a44e5299e553, content=投了另一个杂志，已经接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Tue Nov 29 14:18:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529402, encodeId=cb55529402c2, content=意思是，现在他们觉得有一个其他杂质可能适合你的文章，他们问你是否需要把你的这篇文章转给这个杂志进行审稿。假如该文章接收，这个新杂志将会收取版面费。如果你同意他们就帮你转过去，你就不用再重新走投稿的流程了。Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Nov 15 18:18:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529118, encodeId=50bc529118f0, content=今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Tue Nov 08 12:42:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529056, encodeId=51fd52905603, content=我只写了cover letter，decision letter是什么，第一次发sci，不是很懂，只是按照稿约里写的。我投的是篇case report。我今天用传真传过去了，也不知道那边能不能知道是我的author agreementifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, beContent=ifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Sun Nov 06 14:00:00 CST 2016, time=2016-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529034, encodeId=0a1052903454, content=发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sat Nov 05 21:15:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528925, encodeId=d51052892521, content=投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Thu Nov 03 10:03:00 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528482, encodeId=885652848229, content=您的文章接受了没，希望可以拜读一下miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e191689492, createdName=1de54751m01(暂无匿称), createdTime=Fri Oct 21 12:11:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528368, encodeId=8add5283681c, content=投了个correspondence，昨天已经接收啦。ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=599, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Oct 18 18:01:00 CST 2016, time=2016-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527772, encodeId=b52052e77246, content=投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Fri Sep 30 08:53:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527252, encodeId=2d9552e252f7, content=请问您文章后续怎样啊我的选审稿人都两周了miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Sat Sep 17 09:24:00 CST 2016, time=2016-09-17, status=1, ipAttribution=)]

2016-09-30 ifmorethanten

投稿两天了，一直是submission recieved。请问有知道是为啥吗？

447 0

[GetPortalCommentsPageByObjectIdResponse(id=529975, encodeId=a44e5299e553, content=投了另一个杂志，已经接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Tue Nov 29 14:18:00 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529402, encodeId=cb55529402c2, content=意思是，现在他们觉得有一个其他杂质可能适合你的文章，他们问你是否需要把你的这篇文章转给这个杂志进行审稿。假如该文章接收，这个新杂志将会收取版面费。如果你同意他们就帮你转过去，你就不用再重新走投稿的流程了。Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=Milk An 2016-11-08 发表:: 今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Nov 15 18:18:00 CST 2016, time=2016-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529118, encodeId=50bc529118f0, content=今天回信了，大体意思是拒稿，但是里面一句话我很纳闷，If you would like your manuscript transferred to Hepatology communications and agree to pay these charges should your manuscript be accepted, please simply respond to this email and indicate your consent. The transfer process will be automatic and without the need to reformat or resubmit.上面还说这个肝脏病学通信出版费用是AASLD会员1500美元，非会员2500美元，有人被拒后收到这样的信吗？先感谢各位老师指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Tue Nov 08 12:42:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529056, encodeId=51fd52905603, content=我只写了cover letter，decision letter是什么，第一次发sci，不是很懂，只是按照稿约里写的。我投的是篇case report。我今天用传真传过去了，也不知道那边能不能知道是我的author agreementifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, beContent=ifmorethanten 2016-11-05 发表:: 发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Sun Nov 06 14:00:00 CST 2016, time=2016-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529034, encodeId=0a1052903454, content=发到hepatology@aasld.org就可以了。你的decision letter里应该写了的。仔细看看最后一段。Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=Milk An 2016-11-03 发表:: 投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Sat Nov 05 21:15:00 CST 2016, time=2016-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528925, encodeId=d51052892521, content=投稿后杂志社回信说把author agreement发过去，里面要加上新给的manuscript number，搞好了以后怎么发给他们呢，有知道的吗，谢谢各位大神, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24aa1744058, createdName=Milk An, createdTime=Thu Nov 03 10:03:00 CST 2016, time=2016-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528482, encodeId=885652848229, content=您的文章接受了没，希望可以拜读一下miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=miamihurricane 2016-05-05 发表:: 两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e191689492, createdName=1de54751m01(暂无匿称), createdTime=Fri Oct 21 12:11:00 CST 2016, time=2016-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528368, encodeId=8add5283681c, content=投了个correspondence，昨天已经接收啦。ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=ifmorethanten 2016-09-30 发表:: 投稿两天了，一直是submission recieved。请问有知道是为啥吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=599, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Tue Oct 18 18:01:00 CST 2016, time=2016-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527772, encodeId=b52052e77246, content=投稿两天了，一直是submission recieved。请问有知道是为啥吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c751609628, createdName=ifmorethanten, createdTime=Fri Sep 30 08:53:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527252, encodeId=2d9552e252f7, content=请问您文章后续怎样啊我的选审稿人都两周了miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Sat Sep 17 09:24:00 CST 2016, time=2016-09-17, status=1, ipAttribution=)]

2016-09-17 1dee6910m74(暂无匿称)

请问您文章后续怎样啊我的选审稿人都两周了miamihurricane 2016-05-13 发表::
Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？

miamihurricane 2016-05-13 发表:: Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？

268 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务